title: No enhancement of sensory and motor blockade by neostigmine added to mepivacaine axillary plexus block.
abstract: BACKGROUND
  Intrathecal neostigmine induces analgesia but also several side effects. Recently, 500 microg neostigmine administered intraarticularly was shown to produce postoperative analgesia without side effects. The authors' goal was to determine whether 500 microg neostigmine added to mepivacaine in axillary plexus block prolongs postoperative analgesia. In addition, they wanted to determine the incidence of side effects in patients undergoing hand surgery.
  
  
  METHODS
  Sixty-nine outpatients scheduled for carpal tunnel syndrome repair with axillary plexus block were randomly assigned to one of three groups that received saline solution in the axillary plexus and subcutaneously (group 1), 500 microg neostigmine in the axillary plexus and saline solution subcutaneously (group 2), or saline solution in the axillary plexus and 500 microg neostigmine subcutaneously (group 3). Sensory and motor block in the four hand nerve distributions were assessed every 5 min for 30 min The duration of the sensory and motor blocks were assessed after operation. Side effects were also recorded.
  
  
  RESULTS
  Neostigmine had no effect on sensory and motor block in any of the four nerve distributions, nor did it increase the median duration of sensory block (215 min; range, 120-330 min) compared with group 1 (247 min; range, 190-287 min) or group 3 (236 min; range, 160-280 min). Motor block was slightly shorter (P = 0.045) in group 3 (190 min; range, 135-285 min) compared with group 1 (218 min; range, 145257 min) and group 2 (215 min; range, 105-343 min). Gastrointestinal side effects occurred in 30% of patients in both neostigmine groups but not in group 1 (P < 0.05).
  
  
  CONCLUSIONS
  This study suggests that 500 microg neostigmine added to mepivacaine in axillary plexus block does not prolong postoperative sensory block, but it does cause a relatively high incidence of side effects. These two findings raise doubts about the use of neostigmine associated with local anesthetics for plexus neural block.
authors.affiliation: Department of Anesthesia, Hôpital Antoine Béclère, Calmart, France.
authors.forename: H
authors.initials: H
authors.lastname: Bouaziz
authors.forename: X
authors.initials: X
authors.lastname: Paqueron
authors.forename: M L
authors.initials: ML
authors.lastname: Bur
authors.forename: M
authors.initials: M
authors.lastname: Merle
authors.forename: M C
authors.initials: MC
authors.lastname: Laxenaire
authors.forename: D
authors.initials: D
authors.lastname: Benhamou
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000779:Anesthetics, Local / Q000494:pharmacology*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008619:Mepivacaine / Q000494:pharmacology*; D008875:Middle Aged; D009388:Neostigmine / Q000009:adverse effects / Q000494:pharmacology*; D009407:Nerve Block; D010149:Postoperative Pain / Q000188:drug therapy*; D011446:Prospective Studies; D012677:Sensation / Q000187:drug effects*
chemical_list: D000779:Anesthetics, Local; D002800:Cholinesterase Inhibitors; D009388:Neostigmine; D008619:Mepivacaine